Clinical efficacy of Qianliekang tablets on type Ⅲ prostatitisChinese Full Text
YANG Fei-heng;XIAO Fei;YAO Wen;GAO Yun-sheng;Center for Community Health Service Chaoyang District;Beijing Chuiyangliu Hospital;Health Bureau of Chaoyang District;
Abstract: Objective To evaluate the clinical efficacy of Qianliekang tablets on type Ⅲ prostatitis. Methods A total of 105 patients with typeⅢ prostatitis were enrolled in this study. All patients took 2 g Qianliekang tablets each time for 6 weeks,three times a day. With National Instituted of Health- chronic prostatitis symptom index（ NIH- CPSI） scores and expressed prostatic secretious（ EPS） as evaluating indexes,they were compared before and after treatment. Results The total effective rate of Qianliekang tablets was 84. 3% after six weeks of treatment. There were significant statistical differences in NIH- CPSI scores and the amount of leukocyte in EPS between before treatment and six weeks after treatment（ P ＜0. 05）. Conclusion The results of this study have demonstrated that Qianliekang tablets has a definite clinical effect on treating type Ⅲ prostatitis.
Keywords：
type Ⅲ prostatitis; Qianliekang tablets; National Instituted of Health-chronic prostatitis symptom index; expressed prostatic secretious;
- DOI：
10.13699/j.cnki.1001-6821.2014.09.004
- Series：
- Subject：
- Classification Code：
R697.33
- Mobile Reading
Read on your phone instantly
Step 1Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3
Scan QR Codes
Read this article on your phone.
- HTML
- CAJ Download
- PDF Download
Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 221 Page: 765-766 Pagecount: 2 Size: 152K
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author